Search details
1.
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity.
Nat Cancer
; 2(1): 18-33, 2021 01.
Article
in English
| MEDLINE | ID: mdl-35121890
2.
Immunosuppressive effect of ASP2408, a novel CD86-selective variant of CTLA4-Ig, in rats and cynomolgus monkeys.
Int Immunopharmacol
; 40: 310-317, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27662596
3.
ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution.
Protein Eng Des Sel
; 29(5): 159-67, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26968452
4.
The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates.
Transplantation
; 100(12): 2611-2620, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27861289
5.
lnterleukin-2 Stimulates the Development of Anergy via the Activation of Nonspecific Suppressor T Cells.
Int Arch Allergy Immunol
; 99(2-4): 411-415, 1992.
Article
in English
| MEDLINE | ID: mdl-34167267
Results
1 -
5
de 5
1
Next >
>>